Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Neil Osterweil

    News

    Higher intensity therapy doesn’t increase surgical risk in esophageal cancer

    Author:
    Neil Osterweil
    Publish date: January 20, 2021

    Neither radiation nor docetaxel added to neoadjuvant cisplatin plus 5-fluorouracil increased the risk of perioperative complications when compared...

    • Read More

    News

    Boost dose reduces recurrence in high-risk DCIS

    Author:
    Neil Osterweil
    Publish date: January 20, 2021

    Adding a tumor bed boost to whole breast irradiation cut the risk of local recurrence in half, regardless of fractionation.

    • Read More

    News

    Von Willebrand disease guidelines address women’s bleeding concerns

    Author:
    Neil Osterweil
    Publish date: January 19, 2021

    In the absence of robust evidence, the joint guidelines outline key suggestions for clinical situations covering...

    • Read More

    News

    Bemarituzumab FIGHTs gastric/GEJ cancers, improving survival

    Author:
    Neil Osterweil
    Publish date: January 19, 2021

    Bemarituzumab improved progression-free and overall survival.

    • Read More

    News

    Four-item prognostic index predicts survival in adult Burkitt lymphoma

    Author:
    Neil Osterweil
    Publish date: December 16, 2020

    Patients with zero of four risk factors on the Burkitt Lymphoma International Prognostic Index had excellent 3-...

    • Read More

    News

    Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma

    Author:
    Neil Osterweil
    Publish date: December 15, 2020

    Fifteen of 16 patients with relapsed/refractory multiple myeloma had strong responses to therapy with BCMA- and...

    • Read More

    News

    Adding atezolizumab to chemo doesn’t worsen QOL in early TNBC

    Author:
    Neil Osterweil
    Publish date: December 14, 2020

    After an initial decline, quality of life measures rebounded for patients treated with atezolizumab or placebo plus chemotherapy.

    • Read More

    News

    Pediatric regimens better for adolescents/young adults with aggressive B-cell NHL

    Author:
    Neil Osterweil
    Publish date: December 10, 2020

    The risk of relapse was more than fourfold higher for patients with DLBCL or Burkitt’s lymphoma treated at adult...

    • Read More

    News

    Diabetes prevention diet may lower mortality risk in breast cancer

    Author:
    Neil Osterweil
    Publish date: December 10, 2020

    Among participants in two iterations of the Nurses’ Health Study, healthier diets were linked to lower breast...

    • Read More

    News

    Emotions, worse attention linked to pain-related health care use in SCD

    Author:
    Neil Osterweil
    Publish date: December 9, 2020

    Poorly controlled emotions and poor cognitive test scores were predictors for sickle cell disease pain-related...

    • Read More

    News

    Childhood Hodgkin survivors have neurocognitive impairment

    Author:
    Neil Osterweil
    Publish date: December 7, 2020

    An analysis of survivors showed higher levels of impairment across four domains, but the difference may be...

    • Read More

    News

    Durable responses with anti-BCMA CAR T-cell for multiple myeloma

    Author:
    Neil Osterweil
    Publish date: December 6, 2020

    Seventy-two percent of patients with relapsed/refractory multiple myeloma had ongoing responses at the time of data cutoff in the CARTITUDE-1...

    • Read More

    News

    AASLD 2020: A clinical news roundup

    Author:
    Neil Osterweil
    Publish date: November 25, 2020

    A panel of reviewers highlighted abstracts from the digital edition of the 2020 Liver Meeting in the annual Clinical News Debrief.

    • Read More

    News

    Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide

    Author:
    Neil Osterweil
    Publish date: November 20, 2020

    Patients of White background had a nearly sixfold higher chance for functional cure of hepatitis B infection.

    • Read More

    News

    HCC rates slow in cities, continue to climb in rural areas

    Author:
    Neil Osterweil
    Publish date: November 20, 2020

    Disparities in hepatocellular carcinoma incidence rates between urban and rural areas vary by race/ethnicity.

    • Read More

    Pages

    • « first
    • …
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery